Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes

被引：219

作者：

Molitch, Mark E. ^{[1
]}

Adler, Amanda I. ^{[2
]}

Flyvbjerg, Allan ^{[3
]}

Nelson, Robert G. ^{[4
]}

So, Wing-Yee ^{[5
]}

Wanner, Christoph ^{[6
]}

Kasiske, Bertram L. ^{[7
]}

Wheeler, David C. ^{[8
]}

de Zeeuw, Dick ^{[9
]}

Mogensen, Carl E. ^{[10
,11
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Div Endocrinol, Chicago, IL 60611 USA

[2] Addenbrookes Hosp, Inst Metab Sci, Cambridge, England

[3] Aarhus Univ, Aarhus, Denmark

[4] NIDDK, NIH, Phoenix, AZ USA

[5] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China

[6] Univ Hosp Wurzburg, Wurzburg, Germany

[7] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA

[8] UCL, London, England

[9] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands

[10] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark

[11] Aarhus Univ, Aarhus, Denmark

来源：

KIDNEY INTERNATIONAL | 2015年 / 87卷 / 01期

关键词：

albuminuria; blood pressure; diabetic kidney disease; glycemic control; lipid management; GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE CONTROL; CARDIORENAL END-POINTS; STAGE RENAL-DISEASE; HIGH VASCULAR RISK; GLYCEMIC CONTROL; CYSTATIN C; ALL-CAUSE; COLLABORATIVE METAANALYSIS; CARDIOVASCULAR MORTALITY;

D O I：

10.1038/ki.2014.128

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

The incidence and prevalence of diabetes mellitus (DM) continue to grow markedly throughout the world, due primarily to the increase in type 2 DM (T2DM). Although improvements in DM and hypertension management have reduced the proportion of diabetic individuals who develop chronic kidney disease (CKD) and progress to end-stage renal disease (ESRD), the sheer increase in people developing DM will have a major impact on dialysis and transplant needs. This KDIGO conference addressed a number of controversial areas in the management of DM patients with CKD, including aspects of screening for CKD with measurements of albuminuria and estimated glomerular filtration rate (eGFR); defining treatment outcomes; glycemic management in both those developing CKD and those with ESRD; hypertension goals and management, including blockers of the renin-angiotensin-aldosterone system; and lipid management.

引用

页码：20 / 30

页数：11

共 110 条

[1] Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) [J].

Adler, AI ;

Stevens, RJ ;

Manley, SE ;

Bilous, RW ;

Cull, CA ;

Holman, RR .

KIDNEY INTERNATIONAL, 2003, 63 (01) :225-232

[2] Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration [J].

Altman, Douglas G. ;

McShane, Lisa M. ;

Sauerbrei, Willi ;

Taube, Sheila E. .

PLOS MEDICINE, 2012, 9 (05)

[3]

[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s004, 10.2337/dc35-S011]

[4]

[Anonymous], 2012, The Journal of Clinical and Applied Research and Education, V35, pS1

[5]

[Anonymous], SIGN PUBLICATION

[6]

[Anonymous], CLIN GUID 66 TYP 2 D

[7]

[Anonymous], NEW ENGL J MED

[8]

[Anonymous], CLIN PRACT GUID DIA

[9]

[Anonymous], 2012, KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney International Supplements

[10] Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts [J].

Astor, Brad C. ;

Matsushita, Kunihiro ;

Gansevoort, Ron T. ;

van der Velde, Marije ;

Woodward, Mark ;

Levey, Andrew S. ;

de Jong, Paul E. ;

Coresh, Josef .

KIDNEY INTERNATIONAL, 2011, 79 (12) :1331-1340

← 1 2 3 4 5 6 7 8 9 10 →